2 YEAR
We have extensive product portfolios of innovative and established medicines involved in fields of cardiovascular and cerebrovascular diseases, diabetes, osteoporosis, tumors, etc. The product portfolios are used for 4 fields and 6 divisions of cardio-cerebrovascular therapy, and provide patients with high-quality and comprehensive therapy options. Our core competitiveness arises from high-quality innovative products and marketing driven by robust clinical trials and evidence-based medicine. Our primary therapeutic area focus is cardiovascular and cerebrovascular disease, with active expansion into diabetes, oncology, orthopedics and infectious disease. Through in-house R&D, partnerships, strategic investments, and acquisitions, we are rapidly enriching our pipeline, developing multiple blockbuster products, and building a fully integrated pharmaceutical ecosystem. Guided by unified purpose and international expansion, we will continue to build our high-caliber team.
Read More
